Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 156.11%6.08M | -134.88%-1.94M | 15.96%7.53M | 752.17%21.64M | 60.21%7.22M | -3.42%2.37M | 182.65%5.55M | 281.77%6.49M | 84.51%-3.32M | -5.73%4.51M |
| Net income from continuing operations | -47.91%-23.69M | -536.27%-12.33M | 7.30%-17.02M | 25.08%-48.78M | 30.75%-12.47M | 22.34%-16.02M | 86.19%-1.94M | -47.55%-18.36M | 67.82%-65.1M | 87.13%-18M |
| Operating gains losses | 565.68%6.62M | 65.66%-2.82M | -113.55%-637K | 19.29%-7.74M | 64.69%-2.8M | -119.06%-1.42M | -653.94%-8.22M | 158.54%4.7M | 86.87%-9.59M | 19.06%-7.93M |
| Depreciation and amortization | 0.36%7.8M | 8.00%7.97M | 17.54%8.04M | 12.42%29.89M | 16.16%7.91M | 33.56%7.77M | 11.28%7.38M | -6.80%6.84M | 0.36%26.59M | -37.13%6.81M |
| Asset impairment expenditure | ---- | ---- | ---- | -94.96%432K | ---- | ---- | ---- | ---- | -94.93%8.57M | ---- |
| Remuneration paid in stock | -67.01%357K | 7.78%374K | -120.14%-307K | -47.83%4.22M | -46.27%1.27M | 2.46%1.08M | -85.32%347K | -34.05%1.52M | -64.93%8.09M | -60.36%2.36M |
| Deferred tax | 12.25%8.64M | -20.84%8.95M | 29.88%8.63M | 11.70%28.9M | -46.25%3.25M | -54.54%7.7M | 344.77%11.31M | 1,772.39%6.65M | 248.23%25.87M | 240.53%6.04M |
| Other non cashItems | 9.71%4.04M | 449.18%2.01M | 56.51%2.09M | -38.31%8.45M | -50.36%3.07M | 202.97%3.68M | -92.27%366K | -14.63%1.34M | -36.25%13.71M | 54.45%6.19M |
| Change In working capital | 658.31%2.32M | -64.76%-6.08M | 76.89%6.73M | 154.00%6.19M | 1,301.94%6.49M | 95.59%-415K | 53.00%-3.69M | -28.66%3.8M | -136.65%-11.46M | -92.94%463K |
| -Change in receivables | -541.26%-1.19M | 184.03%2.79M | -551.22%-1.85M | 178.74%1.86M | 123.51%201K | 136.01%269K | 120.40%983K | 133.88%410K | -48.43%-2.37M | 43.93%-855K |
| -Change in inventory | -0.57%-2.48M | 101.17%36K | 156.77%2.05M | 14.53%-4.01M | 51.55%5.14M | -300.57%-2.47M | 36.49%-3.07M | 19.40%-3.61M | -186.86%-4.69M | 198.43%3.39M |
| -Change in prepaid assets | 134.44%703K | 59.11%-397K | -13.51%781K | -474.75%-1.51M | 471.88%595K | -397.09%-2.04M | 68.80%-971K | -69.79%903K | -75.17%404K | 83.94%-160K |
| -Change in payables and accrued expense | 38.11%5.28M | -1,238.68%-8.51M | -5.80%5.75M | 304.64%9.85M | 128.88%553K | 136.19%3.83M | -77.65%-636K | -24.04%6.1M | -119.96%-4.81M | -117.74%-1.92M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 156.11%6.08M | -134.88%-1.94M | 15.96%7.53M | 750.06%21.57M | 58.66%7.15M | -3.42%2.37M | 182.65%5.55M | 281.77%6.49M | 84.51%-3.32M | -5.73%4.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -590.65%-5.32M | -126.97%-459K | -488.83%-4.38M | -10.56%-7.07M | -2,112.20%-7.26M | 7.89%-770K | 348.10%1.7M | 83.64%-743K | 92.09%-6.39M | 95.76%-328K |
| Net PPE purchase and sale | -531.95%-4.87M | -108.15%-166K | -273.35%-4.02M | 56.18%-4.71M | -4.66%-4.9M | 7.89%-770K | 396.79%2.04M | 76.29%-1.08M | 81.11%-10.74M | 38.84%-4.68M |
| Net intangibles purchas and sale | ---452K | ---293K | ---354K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---5.21M | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | ---- | ---- | ---- | -34.54%2.85M | ---- | ---- | ---- | --334K | 245.03%4.35M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -590.65%-5.32M | -126.97%-459K | -488.83%-4.38M | -10.56%-7.07M | -2,112.20%-7.26M | 7.89%-770K | 348.10%1.7M | 83.64%-743K | 92.09%-6.39M | 95.76%-328K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 101.21%166K | 90.59%-262K | 152.18%3.39M | -276.37%-24.46M | 56.86%-1.44M | -327.47%-13.74M | -113.85%-2.78M | -2,061.03%-6.49M | -59.19%13.87M | -59.51%-3.35M |
| Net issuance payments of debt | 110.68%1.27M | 80.05%-604K | 167.03%3.99M | -261.38%-21.44M | 82.54%-568K | -363.24%-11.9M | -116.71%-3.03M | -695.90%-5.95M | -20.64%13.29M | 24.35%-3.25M |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --39K | --0 | --32K | --5K | --2K | --0 | --0 |
| Net other financing activities | 41.25%-1.1M | 43.70%342K | -11.67%-603K | -625.99%-3.06M | -851.09%-875K | -190.42%-1.88M | -88.03%238K | 19.16%-540K | -75.33%581K | -104.09%-92K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 101.21%166K | 90.59%-262K | 152.18%3.39M | -276.37%-24.46M | 56.86%-1.44M | -327.47%-13.74M | -113.85%-2.78M | -2,061.03%-6.49M | -59.19%13.87M | -59.51%-3.35M |
| Net cash flow | ||||||||||
| Beginning cash position | -27.97%25.23M | -8.76%27.89M | -31.81%21.35M | 15.32%31.31M | -24.87%22.89M | 9.26%35.03M | 57.35%30.56M | 15.32%31.31M | -71.57%27.15M | -4.82%30.47M |
| Current changes in cash | 107.64%928K | -159.47%-2.66M | 982.73%6.54M | -339.46%-9.96M | -284.81%-1.55M | -662.02%-12.14M | -64.83%4.47M | 90.48%-741K | 106.09%4.16M | 116.55%836K |
| Effect of exchange rate changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| End cash Position | 14.28%26.16M | -27.97%25.23M | -8.76%27.89M | -31.81%21.35M | -31.81%21.35M | -24.87%22.89M | 9.26%35.03M | 57.35%30.56M | 15.32%31.31M | 15.32%31.31M |
| Free cash from | -52.49%762K | -230.51%-6.34M | -41.77%3.15M | 219.91%16.86M | 131.52%4.98M | 639.17%1.6M | 158.46%4.86M | 166.75%5.42M | 82.04%-14.06M | 175.00%2.15M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.